NCT02087345

Brief Summary

Dental erosions, the chemical dissolution of enamel without bacterial involvement, are considered to be an established complication of gastroesophageal reflux disease (GERD) by the Montreal global consensus statement. Given the high prevalence of dental erosions and the absence of any pH-impedance data or medical management guidelines for GERD-associated dental erosions, reflux characteristics will be characterized using questionnaires, endoscopy and esophageal pH-impedance testing, in successive patients dental erosions referred by dentists for evaluation of GERD. For assessment of the role of additional factors besides H+ activity in the refluxate, a sample of gastric juice will be aspirated during endoscopy and frozen for analysis of pepsin and other proteases. Prognostic factors for progression of dental erosions will be determined by repeating the evaluation after chronic dosing with esomeprazole 20mg twice-daily, which is prescribed to all patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 10, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 14, 2014

Completed
4.8 years until next milestone

Study Start

First participant enrolled

December 15, 2018

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

March 30, 2021

Status Verified

March 1, 2021

Enrollment Period

4 years

First QC Date

March 10, 2014

Last Update Submit

March 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The % of time with pH<4 and 5.5 during 24-hour pH-impedance

    1 year

Secondary Outcomes (1)

  • The number of acidic and weakly acidic reflux episodes during 24-hour pH-impedance

    1 year

Other Outcomes (1)

  • Association between dental erosion grades, gastric juice pepsin conc. and reflux episodes and % time with pH<4 and <5.5 during 24-hour pH-impedance

    1 year

Study Arms (1)

Dental erosions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Successive male and female patients with dental erosions

You may qualify if:

  • Successive male and female patients
  • Over 18 years of age presenting to the University of Bern Department of Dentistry and affiliated dentists
  • Dental erosions

You may not qualify if:

  • Non-reflux causes of erosion
  • Reduced salivary flow and buffering capacity
  • History of bruxism, eating disorders, recurrent vomiting, severe obesity (BMI\>35kg/m2) or past bariatric surgery
  • Dietary or abrasive causes for dental erosion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gastroenterology Group Practice

Bern, Switzerland

RECRUITING

Related Publications (1)

  • Wilder-Smith CH, Materna A, Martig L, Lussi A. Longitudinal study of gastroesophageal reflux and erosive tooth wear. BMC Gastroenterol. 2017 Oct 25;17(1):113. doi: 10.1186/s12876-017-0670-1.

Biospecimen

Retention: NONE RETAINED

gastric juice

MeSH Terms

Conditions

Tooth ErosionGastroesophageal Reflux

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic DiseasesTooth WearEsophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Clive Wilder-Smith, MD

    Brain-Gut Reserach Group

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Clive Wilder-Smith, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2014

First Posted

March 14, 2014

Study Start

December 15, 2018

Primary Completion

December 1, 2022

Study Completion

June 1, 2023

Last Updated

March 30, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations